Radial versus femoral artery access for percutaneous coronary artery intervention in patients with acute myocardial infarction and multivessel disease complicated by cardiogenic shock: Subanalysis from the CULPRIT-SHOCK trial

Authors:

Abstract
No abstract available
Funding Information
  • Novartis
  • Fédération Française de Cardiologie
  • Sanofi
  • Seventh Framework Programme
  • Medtronic
  • Biotronik
  • Gilead Sciences
  • Institut Servier
  • Daiichi Sankyo Company
  • Bayer
  • Daiichi-Sankyo
  • Amgen
  • Boston Scientific Corporation
  • AstraZeneca France
  • Bristol-Myers Squibb
  • Sanofi Pasteur
  • Boehringer Ingelheim France
  • Eli Lilly and Company
  • Medicines Company
  • Pfizer
  • Deutsche Stiftung für Herzforschung
  • Johnson & Johnson Innovative Medicine
  • Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung.
  • Abbott Laboratories
  • Meso Scale Diagnostics
  • Institut de Recherches Servier

This publication has 36 references indexed in Scilit: